-
[1]
Ningyue Xu
, Jun Wang
, Lei Liu
, Changyang Gong
. Injectable hydrogel-based drug delivery systems for enhancing the efficacy of radiation therapy: A review of recent advances. Chinese Chemical Letters,
2024, 35(8): 109225-.
doi: 10.1016/j.cclet.2023.109225
-
[2]
Zhilong Xie
, Guohui Zhang
, Ya Meng
, Yefei Tong
, Jian Deng
, Honghui Li
, Qingqing Ma
, Shisong Han
, Wenjun Ni
. A natural nano-platform: Advances in drug delivery system with recombinant high-density lipoprotein. Chinese Chemical Letters,
2024, 35(11): 109584-.
doi: 10.1016/j.cclet.2024.109584
-
[3]
Linghui Zou
, Meng Cheng
, Kaili Hu
, Jianfang Feng
, Liangxing Tu
. Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters,
2024, 35(7): 109129-.
doi: 10.1016/j.cclet.2023.109129
-
[4]
Fengjie Liu
, Fansu Meng
, Zhenjiang Yang
, Huan Wang
, Yuehong Ren
, Yu Cai
, Xingwang Zhang
. Exosome-biomimetic nanocarriers for oral drug delivery. Chinese Chemical Letters,
2024, 35(9): 109335-.
doi: 10.1016/j.cclet.2023.109335
-
[5]
Jiechen Liu
, Xiaoguang Li
, Ruiyang Xia
, Yuqi Wang
, Fenghe Zhang
, Yongzhi Pang
, Qing Li
. Efficient suppression of oral squamous cell carcinoma through spatial dimension conversion drug delivery systems-enabled immunomodulatory-photodynamic therapy. Chinese Chemical Letters,
2024, 35(12): 109619-.
doi: 10.1016/j.cclet.2024.109619
-
[6]
Yujie Li
, Ya-Nan Wang
, Yin-Gen Luo
, Hongcai Yang
, Jinrui Ren
, Xiao Li
. Advances in synthetic biology-based drug delivery systems for disease treatment. Chinese Chemical Letters,
2024, 35(11): 109576-.
doi: 10.1016/j.cclet.2024.109576
-
[7]
Haijun Shen
, Yi Qiao
, Chun Zhang
, Yane Ma
, Jialing Chen
, Yingying Cao
, Wenna Zheng
. A matrix metalloproteinase-sensitive hydrogel combined with photothermal therapy for transdermal delivery of deferoxamine to accelerate diabetic pressure ulcer healing. Chinese Chemical Letters,
2024, 35(12): 110283-.
doi: 10.1016/j.cclet.2024.110283
-
[8]
Linjie Ju
, Zhongxi Huang
, Qian Shen
, Chan Fu
, Shuanghe Li
, Wenjie Duan
, Chenfeng Xu
, Weizhen An
, Zhiqiang Zhai
, Jifu Wei
, Changmin Yu
, Guoren Zhou
. Glutathione depletion based Pt(Ⅳ) hybrid mesoporous organosilica delivery system to conquer cisplatin chemoresistance: A “one stone three birds” strategy. Chinese Chemical Letters,
2024, 35(10): 109450-.
doi: 10.1016/j.cclet.2023.109450
-
[9]
Zhaomin Tang
, Qian He
, Jianren Zhou
, Shuang Yan
, Li Jiang
, Yudong Wang
, Chenxing Yao
, Huangzhao Wei
, Keda Yang
, Jiajia Wang
. Active-transporting of charge-reversal Cu(Ⅱ)-doped mesoporous silica nanoagents for antitumor chemo/chemodynamic therapy. Chinese Chemical Letters,
2024, 35(7): 109742-.
doi: 10.1016/j.cclet.2024.109742
-
[10]
Qiang Li
, Jiangbo Fan
, Hongkai Mu
, Lin Chen
, Yongzhen Yang
, Shiping Yu
. Nucleus-targeting orange-emissive carbon dots delivery adriamycin for enhanced anti-liver cancer therapy. Chinese Chemical Letters,
2024, 35(6): 108947-.
doi: 10.1016/j.cclet.2023.108947
-
[11]
Du Liu
, Yuyan Li
, Hankun Zhang
, Benhua Wang
, Chaoyi Yao
, Minhuan Lan
, Zhanhong Yang
, Xiangzhi Song
. Three-in-one erlotinib-modified NIR photosensitizer for fluorescence imaging and synergistic chemo-photodynamic therapy. Chinese Chemical Letters,
2025, 36(2): 109910-.
doi: 10.1016/j.cclet.2024.109910
-
[12]
Yi Cao
, Xiaojiao Ge
, Yuanyuan Wei
, Lulu He
, Aiguo Wu
, Juan Li
. Tumor microenvironment-activatable neuropeptide-drug conjugates enhanced tumor penetration and inhibition via multiple delivery pathways and calcium deposition. Chinese Chemical Letters,
2024, 35(4): 108672-.
doi: 10.1016/j.cclet.2023.108672
-
[13]
Ji Liu
, Dongsheng He
, Tianjiao Hao
, Yumin Hu
, Yan Zhao
, Zhen Li
, Chang Liu
, Daquan Chen
, Qiyue Wang
, Xiaofei Xin
, Yan Shen
. Gold mineralized "hybrid nanozyme bomb" for NIR-II triggered tumor effective permeation and cocktail therapy. Chinese Chemical Letters,
2024, 35(9): 109296-.
doi: 10.1016/j.cclet.2023.109296
-
[14]
Lulu Cao
, Yikun Li
, Dongxiang Zhang
, Shuai Yue
, Rong Shang
, Xin-Dong Jiang
, Jianjun Du
. Engineering aggregates of julolidine-substituted aza-BODIPY nanoparticles for NIR-II photothermal therapy. Chinese Chemical Letters,
2024, 35(12): 109735-.
doi: 10.1016/j.cclet.2024.109735
-
[15]
Yihan Zhou
, Duo Gao
, Yaying Wang
, Li Liang
, Qingyu Zhang
, Wenwen Han
, Jie Wang
, Chunliu Zhu
, Xinxin Zhang
, Yong Gan
. Worm-like micelles facilitate the intestinal mucus diffusion and drug accumulation for enhancing colorectal cancer therapy. Chinese Chemical Letters,
2024, 35(6): 108967-.
doi: 10.1016/j.cclet.2023.108967
-
[16]
Ze Wang
, Hao Liang
, Annan Liu
, Xingchen Li
, Lin Guan
, Lei Li
, Liang He
, Andrew K. Whittaker
, Bai Yang
, Quan Lin
. Strength through unity: Alkaline phosphatase-responsive AIEgen nanoprobe for aggregation-enhanced multi-mode imaging and photothermal therapy of metastatic prostate cancer. Chinese Chemical Letters,
2025, 36(2): 109765-.
doi: 10.1016/j.cclet.2024.109765
-
[17]
Yunjie Dang
, Yanru Feng
, Xiao Chen
, Chaoxing He
, Shujie Wei
, Dingyang Liu
, Jinlong Qi
, Huaxing Zhang
, Shaokun Yang
, Zhiyun Niu
, Bai Xiang
. Development of a multi-level pH-responsive lipid nanoplatform for efficient co-delivery of siRNA and small-molecule drugs in tumor treatment. Chinese Chemical Letters,
2024, 35(12): 109660-.
doi: 10.1016/j.cclet.2024.109660
-
[18]
Makhloufi Zoulikha
, Zhongjian Chen
, Jun Wu
, Wei He
. Approved delivery strategies for biopharmaceuticals. Chinese Chemical Letters,
2025, 36(2): 110225-.
doi: 10.1016/j.cclet.2024.110225
-
[19]
Jiaqi Huang
, Renjiang Kong
, Yanmei Li
, Ni Yan
, Yeyang Wu
, Ziwen Qiu
, Zhenming Lu
, Xiaona Rao
, Shiying Li
, Hong Cheng
. Feedback enhanced tumor targeting delivery of albumin-based nanomedicine to amplify photodynamic therapy by regulating AMPK signaling and inhibiting GSTs. Chinese Chemical Letters,
2024, 35(8): 109254-.
doi: 10.1016/j.cclet.2023.109254
-
[20]
Wenjia Wang
, Xingyue He
, Xiaojie Wang
, Tiantian Zhao
, Osamu Muraoka
, Genzoh Tanabe
, Weijia Xie
, Tianjiao Zhou
, Lei Xing
, Qingri Jin
, Hulin Jiang
. Glutathione-depleted cyclodextrin pseudo-polyrotaxane nanoparticles for anti-inflammatory oxaliplatin (Ⅳ) prodrug delivery and enhanced colorectal cancer therapy. Chinese Chemical Letters,
2024, 35(4): 108656-.
doi: 10.1016/j.cclet.2023.108656